These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 31035653)
1. Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications. Nagappan A; Shin J; Jung MH Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035653 [TBL] [Abstract][Full Text] [Related]
3. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice. Han JH; Shin H; Park JY; Rho JG; Son DH; Kim KW; Seong JK; Yoon SH; Kim W FASEB J; 2019 Mar; 33(3):4314-4326. PubMed ID: 30566396 [TBL] [Abstract][Full Text] [Related]
4. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future. Simon V; Cota D Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151 [TBL] [Abstract][Full Text] [Related]
5. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. Cooper ME; Regnell SE Br J Clin Pharmacol; 2014 Jan; 77(1):21-30. PubMed ID: 23452341 [TBL] [Abstract][Full Text] [Related]
10. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. Kim W; Doyle ME; Liu Z; Lao Q; Shin YK; Carlson OD; Kim HS; Thomas S; Napora JK; Lee EK; Moaddel R; Wang Y; Maudsley S; Martin B; Kulkarni RN; Egan JM Diabetes; 2011 Apr; 60(4):1198-209. PubMed ID: 21346174 [TBL] [Abstract][Full Text] [Related]
11. Peripheral CB1R as a modulator of metabolic inflammation. Han JH; Kim W FASEB J; 2021 Apr; 35(4):e21232. PubMed ID: 33715173 [TBL] [Abstract][Full Text] [Related]
12. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats. Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
14. Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Song D; Bandsma RH; Xiao C; Xi L; Shao W; Jin T; Lewis GF Diabetologia; 2011 May; 54(5):1181-9. PubMed ID: 21340622 [TBL] [Abstract][Full Text] [Related]
15. Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice. Tang Y; Ho G; Li Y; Hall MA; Hills RL; Black SC; Liang Y; Demarest KT PLoS One; 2012; 7(8):e42134. PubMed ID: 22870290 [TBL] [Abstract][Full Text] [Related]
17. CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity. Zizzari P; He R; Falk S; Bellocchio L; Allard C; Clark S; Lesté-Lasserre T; Marsicano G; Clemmensen C; Perez-Tilve D; Finan B; Cota D; Quarta C Diabetes; 2021 Feb; 70(2):415-422. PubMed ID: 33144338 [TBL] [Abstract][Full Text] [Related]
18. Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice. Chen B; Hu N Braz J Med Biol Res; 2017 May; 50(6):e6141. PubMed ID: 28492810 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox. Dao M; François H Front Endocrinol (Lausanne); 2021; 12():720734. PubMed ID: 34305821 [TBL] [Abstract][Full Text] [Related]
20. Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells. Shin H; Han JH; Yoon J; Sim HJ; Park TJ; Yang S; Lee EK; Kulkarni RN; Egan JM; Kim W J Cell Mol Med; 2018 Apr; 22(4):2337-2345. PubMed ID: 29431265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]